CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 9, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today its product and business goals for 2006, including financial guidance.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 9, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today its product and business goals for 2006, including financial guidance.
